Identification, Mitigation, and Disclosure of Relevant Financial Relationships 
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months. 

Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States. 

DISCLOSURE STATEMENTS:
Absence of Relevant Financial Relationships
The planners, faculty, and others in control of educational content have no relevant financial relationships with ineligible companies.
 

Planners:

Marly Christenson, PhD, MS, RN, NP, CPHQ
Senior Director
Vizient

Shireen Elnaggar, MBA
Member Education and Learning Director
Vizient

Susan Hogan, RN
Consulting Director
Vizient

Lisa McClain, RN    
Networks Manager
Vizient 

Blane Schilling, MD
Senior Principal
Vizient

Presenters:

Deborah Roy, BSN, CMRP, CCM
Principal
Vizient

Tami Mauer, BS
VP, Contract and Program Services
Vizient

Kate Lizzi, MBA, PMP
Senior Consulting Director
Vizient